Literature DB >> 12149931

[Quality of life after acetabulum and pelvic ring fractures. Correlation of long-term results with the "Injury Severity Score" (ISS)].

K Weber1, H Kohler, B Vock, A Wentzensen.   

Abstract

Patients with acetabular (AF) and pelvic ring fractures (BrF) make heavy demands on hospital resources and face difficulties in rehabilitation. From the patients' point of view, milestones in recovery are quality of life and return to productivity. We studied 42 patients with acetabular and 64 patients with pelvic ring fractures over a period of 10 years. The average follow-up took place 4 years after discharge. The injury severity score (ISS) did not correlate to long-term disability and quality of life (QoL) based on the Rosser index, data on return to productivity, or to radiological and clinical outcome. This study emphasizes the need for new injury scoring systems that better predict the recovery and ability to return to work of trauma patients after surviving pelvic fractures. Proper follow-up evaluations should analyze the patients' quality of life and working activity beside traditional items such as radiological and clinical findings.

Entities:  

Mesh:

Year:  2002        PMID: 12149931     DOI: 10.1007/s00132-002-0311-3

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  2 in total

1.  Long-term outcome in 324 polytrauma patients: what factors are associated with posttraumatic stress disorder and depressive disorder symptoms?

Authors:  Lisa Falkenberg; Christian Zeckey; Philipp Mommsen; Marcel Winkelmann; Boris A Zelle; Martin Panzica; Hans-Christoph Pape; Christian Krettek; Christian Probst
Journal:  Eur J Med Res       Date:  2017-10-30       Impact factor: 2.175

2.  Radiological and Functional Assessment of Treatment Outcomes in Patients after Open Reduction with Internal Fixation (ORIF) of Acetabular Fractures.

Authors:  Emilia Dadura; Aleksandra Truszczyńska-Baszak; Dariusz Szydłowski
Journal:  Int J Environ Res Public Health       Date:  2022-01-24       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.